2021 Revenues ($USD) : $7,024,500,000
2021 R&D spend : $372,000,000
2021 Number of Employees : 20,000
Fiscal Year End : 12/31/2020
Key People : Bryan Hanson, chair, president and CEO; Rachel Ellingson, SVP and chief strategy officer; Ellie Humphrey, SVP and chief transformation officer; Vafa Jamali, CEO, ZimVie; David Kunz, SVP, global quality and regulatory affairs; Angela Main, SVP, global chief compliance officer and associate general counsel, Asia Pacific; Keri Mattox, SVP, investor relations and chief communications officer; Carrie Nichol, VP, controller and chief accounting officer (outgoing); Chad Phipps, SVP, general counsel and secretary; Zeeshan Tariq, SVP and chief information officer; Ivan Tornos, chief operating officer; Kenneth Tripp, SVP, global operations and logistics; Suketu Upadhyay, EVP & CFO; Lori Winkler, SVP and chief human resources officer; Sang Yi, group president, Asia Pacific; Wilfred van Zuilen, president, EMEA.

About the company: Zimmer Biomet designs, manufactures and sells orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic (CMFT) products; dental implants; and related surgical products. Founded in Warsaw, Indiana as Zimmer Manufacturing Co. in 1927, the company spun off from Bristol-Myers Squibb in 2001 and acquired Biomet parent company LVB Acquisition in 2015. Its knee replacement brands include Persona, NexGen, Vanguard and Oxford, while its hip brands include Taperloc, Zimmer M/L Taper Hip Prosthesis, Avenir Complete Hip, Arcos Modular Hip, Continuum Acetabular System and the G7 Acetabular System. Zimmer Biomet has four robotically-assisted surgery systems under the Rosa name for hip, knee, spine and brain procedures. In 2021, Zimmer Biomet launched its ZBEdge platform for collecting and sharing data between sensor-enabled implants, surgical systems and apps for physicians and patients. ZB has been making bold, aggressive moves this year. Its launch of a smart knee implant — the Persona IQ — in partnership with Canary Medical was an industry first. The company plans to become leaner and more focused next year through the spinoff of its spine and dental businesses into a new company called ZimVie. – JH